13-07-2026 08:10
via wallstreet-online.de
Faron Provides Update on Investigator-Initiated Trial Portfolio for Bexmarilimab
Investigators update from BLAZE in checkpoint-resistant solid tumors highlights continued progress across Faron's expanding Investigator-Initiated Trial (IIT) portfolio TURKU, FI / ACCESS Newswire / July 13, 2026 / Faron Pharmaceuticals Ltd. …
Weiterlesen »
Analysten nachrichten
